GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (NYSE:LLY) » Definitions » 3-Year Dividend Growth Rate

LLY (Eli Lilly and Co) 3-Year Dividend Growth Rate : 15.20% (As of Sep. 2024)


View and export this data going back to 1970. Start your Free Trial

What is Eli Lilly and Co 3-Year Dividend Growth Rate?

Eli Lilly and Co's Dividends per Share for the three months ended in Sep. 2024 was $1.30.

The historical rank and industry rank for Eli Lilly and Co's 3-Year Dividend Growth Rate or its related term are showing as below:

LLY' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0.7   Med: 7.9   Max: 20.2
Current: 15.2

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Eli Lilly and Co was 20.20% per year. The lowest was 0.70% per year. And the median was 7.90% per year.

LLY's 3-Year Dividend Growth Rate is ranked better than
57.79% of 308 companies
in the Drug Manufacturers industry
Industry Median: 11.45 vs LLY: 15.20

During the past 12 months, Eli Lilly and Co's average Dividends Per Share Growth Rate was 15.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 15.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 15.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Eli Lilly and Co's Dividend Payout Ratio for the three months ended in Sep. 2024 was 1.10. As of today, Eli Lilly and Co's Dividend Yield % is 0.61%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Eli Lilly and Co's 3-Year Dividend Growth Rate

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's 3-Year Dividend Growth Rate falls into.



Eli Lilly and Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Eli Lilly and Co  (NYSE:LLY) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Eli Lilly and Co's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=1.3/ 1.18
=1.10

During the past 13 years, the highest Dividend Payout Ratio of Eli Lilly and Co was 0.72. The lowest was 0.37. And the median was 0.49.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Eli Lilly and Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 1.3000002024-08-152024-08-152024-09-10Cash DividendquarterlyUSD:USD 1.000000
USD 1.3000002024-05-152024-05-162024-06-10Cash DividendquarterlyUSD:USD 1.000000
USD 1.3000002024-02-142024-02-152024-03-08Cash DividendquarterlyUSD:USD 1.000000
USD 1.1300002023-11-142023-11-152023-12-08Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Eli Lilly and Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=5.03/829.74
=0.61 %

Current Share Price is $829.74.
Eli Lilly and Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is $5.03.

During the past 13 years, the highest Dividend Yield of Eli Lilly and Co was 3.00%. The lowest was 0.51%. And the median was 1.94%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eli Lilly and Co 3-Year Dividend Growth Rate Related Terms>


Eli Lilly and Co Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Executives
Lilly Endowment Inc 10 percent owner 2801 NORTH MERIDIAN ST, INDIANAPOLIS IN 46208
Donald A Zakrowski officer: Chief Accounting Officer LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Johna Norton officer: Senior VP, Global Quality LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Alonzo Weems officer: SVP, ERM & CECO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Patrik Jonsson officer: SVP and Pres., Lilly Bio-Meds LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Anne E. White officer: SVP & Pres-Lilly Oncology LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Eric Dozier officer: EVP, HR & Diversity LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jackson P Tai director
Mary Lynne Hedley director C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Marschall S Runge director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Naarden Jacob Van officer: SVP, CEO LoxoONC, Pres LlyONC C/O ELI LILLY & CO, LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Diogo Rau officer: SVP & CIDO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Edgardo Hernandez officer: SVP & Pres., Mfg. Operations LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Kimberly H Johnson director C/O FANNIE MAE, 1100 15TH STREET, NW, WASHINGTON DC 20005
Anat Ashkenazi officer: SVP & CFO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285